Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or Obesity

NCT03072901 is registered in ClinicalTrials.gov with Morphic Medical Inc. as lead sponsor.

NCT NCT03072901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03072901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or Obesity
Lead sponsor
Morphic Medical Inc.
Phase
Observational
Overall status
Terminated
Start date
December 31, 2010
Completion date
February 29, 2016
Enrollment
244 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, type 2 diabetes